International Feminist Critiques of Breast Cancer Culture

BCC partners Grazia de Michele and Ana Porroche Escudero participated in an influential public event on breast cancer this past October held at Marienea, Basauri’s Women’s Association in Bilbao, Spain. The event was sponsored by the Women’s Institute of the Basque Country (Emakunde-Emakumearen Euskal Erakundea), the premier group responsible for promoting, advising, and assessing gender . . . → Read More: International Feminist Critiques of Breast Cancer Culture

Health News Review Interview with Dr. Otis Brawley on Overdiagnosis

“Podcast: Pathologic profiling – Dr. Otis Brawley on cancer overdiagnosis” by Gary Schwitzer, Health News Review.

It its 5th in a series of podcasts on overdiagnosis, Health News Review publisher Gary Schwitzer speaks with chief medical officer of the American Cancer Society, Dr. Otis Brawley.

The in-depth interview was a refreshing break from usual discussions . . . → Read More: Health News Review Interview with Dr. Otis Brawley on Overdiagnosis

Backlash Against “Pinkwashing” of Breast Cancer Awareness Campaigns

Journalist Meg Carter interviewed Breast Cancer Consortium founder Gayle Sulik for this October 12, 2015 article in the BMJ on how big business is keen to jump on the breast cancer awareness bandwagon, and whether its messages around screening do more harm than good.

Here is an excerpt.

. . . → Read More: Backlash Against “Pinkwashing” of Breast Cancer Awareness Campaigns

How Should We Address Breast Cancer When Norms Continually Change?

Accompanying Photograph: Andy Katz/Demotix/Corbis

When faced with decisions about breast cancer treatment or screening, it can be hard to know what to think.

Gayle Sulik, The Guardian, Oct. 20, 2015

Three decades ago, researchers believed breast cancer was one disease, so it made sense to treat it that . . . → Read More: How Should We Address Breast Cancer When Norms Continually Change?

Spotlight: National Breast Cancer Coalition

The National Breast Cancer Coalition (NBCC) is a nationwide advocacy organization founded in 1991 as a broad-based network of grassroots supporters and member organizations that included both breast cancer groups as well as groups focused on all cancers. Member organizations would maintain their own agendas for support, education, and advocacy. But as a coalition, they . . . → Read More: Spotlight: National Breast Cancer Coalition

“Period, end of discussion?” Not so fast. Breast surgeon sidesteps mammography screening debate.

An interview on NPR’s Fresh Air between Terry Gross and Dr. Elisa Port, chief of breast surgery at Mount Sinai Medical Center, touched upon breast cancer screening, cancer spread, surgical removal of a healthy breast, genetic testing, and general changes in treatment over the years. Unfortunately, it missed the boat on the most hot-button issue . . . → Read More: “Period, end of discussion?” Not so fast. Breast surgeon sidesteps mammography screening debate.

Nurse Navigators for Cancer Patients: Do They Help?

When I was diagnosed with breast cancer in 2008, nurse navigators were not available everywhere, and there were none in my locale. Since there was a multi-hospital, dedicated breast health center, I could, if I chose, schedule visits and coordinate communication with my surgeon, my radiation oncologist, and my medical oncologist through the center rather . . . → Read More: Nurse Navigators for Cancer Patients: Do They Help?

This is why you shouldn’t believe that exciting new medical study

“This is why you shouldn’t believe that exciting new medical study,” by Julia Belluz, Vox.

In 2003, researchers writing in the American Journal of Medicine discovered something that should change how you think about medical news. They looked at 101 studies published in top scientific journals between 1979 and 1983 that claimed a new therapy . . . → Read More: This is why you shouldn’t believe that exciting new medical study

The 21st Century Cures Act

In May 2015, the “21st Century Cures Act” was introduced in the U.S. House of Representatives with the goal of promoting the development and speeding the approval of new drugs and devices. Championed by the pharmaceutical, biotechnology, and device industries, some of its provisions could have a significant impact on clinical trial design, what is . . . → Read More: The 21st Century Cures Act

The full story on breast cancer screening. But do you want to listen?

“The full story on breast cancer screening. But do you want to listen?,” by Kenneth Lin, MD, MedPage Today’s KevinMD.com.

The Men Against Breast Cancer Fund and several cancer advocacy and physician organizations have posted a petition on Change.org asking Congress to place a two-year moratorium on finalizing the U.S. Preventive Services Task Force’s draft . . . → Read More: The full story on breast cancer screening. But do you want to listen?

Articles & Posts